Welcome - Home - Register - Login - Help/FAQ - 0 items

Search Enter keywords, a title or a report id number below. In All Categories --------------------- Telecom & Computing Business & Finance Mfg & Construction Pharma & Healthcare Consumer & Retail Gov & Public Sector Energy & Transport Country Reports Company Reports --------------------- Transcripts Advanced      Select a currency for use throughout the site Australia Dollars Canada Dollars Euro Japan Yen Sweden Kroner Switzerland Francs UK Pounds US Dollars Search Results Your Search for 'Genzyme Corporation - Financial and Strategic Analysis Review' returned 30 results - Page 1 of 2   Sort by    Report Name ASC Report Name DESC Report Price ASC Report Price DESC Rank ASC Rank DESC   Sorted by Rank Top-Bottom Genzyme IMS Company Profile   IMS Health, Dec 2008, Pages: 103 592250, Genzyme IMS Company Profile, This ... Therapeutic focus - R&D strategy - Licensing activities ... potential impact Financial Review Company sales performance as ... Procter & Gamble: Pipeline, Products, Performance and Potential   Espicom Business Intelligence Ltd, Nov 2008, Pages: 60 ... full 5-year financial performance assessment ... Chemokine Therapeutics Corporation - Cincinnati Children ... Curis Inc - Genzyme Corporation - Nastech Pharmacecutical ... Wyeth: Performance, Products, Pipeline and Potential   Espicom Business Intelligence Ltd, March 2008, Pages: 152 ... The company's financial performance is covered in-depth, from ... Chiroscience Corixa Corporation Curis Elan Corporation Exelixis Genzyme Biosurgery Inc ... Mentor Medical Device Company Intelligence Report   Espicom Business Intelligence Ltd, Aug 2009, Pages: 32 ... R&D, as well as a full, in-depth five year financial analysis. ... More than 60 Medical Device Company Intelligence Reports are ... Misonix - Genzyme - Tutogen Medical ... US Orthopedic Devices Market Analysis & Forecasts to 2015   GlobalData, March 2009, Pages: 249 ... Company Profile 178 17.8 Genzyme Corporation Company Profile 183 17.9 Osteotech, Inc. ... Company Profile 199 18 Financial Deals Landscape 200 18.1 Acquisition ... Bayer: Performance, Products, Pipeline and Potential   Espicom Business Intelligence Ltd, Oct 2009, Pages: 172 ... SUMMARY 5 Introduction 5 Financial Performance 2007 6 ... Research and Development Strategy 18 Key ... Inc - Genstruct Inc - Genzyme Corporation - GlaxoSmithKline - GW ... Argentina Orthopedic Devices Investment Opportunities, Analysis and Forecasts to 2015   Global Markets Direct, May 2009, Pages: 182 ... description, strategic analysis, and financial information. ... Product and brand updates, strategy changes, R&D ... Chain Analysis 16.11 Genzyme Corporation 16.11.1 ... Mexico Orthopedic Devices Investment Opportunities, Analysis and Forecasts to 2015   Global Markets Direct, May 2009, Pages: 189 ... description, strategic analysis, and financial information. ... Product and brand updates, strategy changes, R&D ... Chain Analysis 16.11 Genzyme Corporation 16.11.1 ... Australia Orthopedic Devices Investment Opportunities, Analysis and Forecasts to 2015   Global Markets Direct, May 2009, Pages: 220 ... description, strategic analysis, and financial information ... Product and brand updates, strategy changes, R&D ... 183 Table 145: Genzyme Corporation Pipeline Products ... United States Orthopedic Devices Investment Opportunities, Analysis and Forecasts to 2015   Global Markets Direct, May 2009, Pages: 273 ... 16.19.1 Company Overview 17 Financial Deals Landscape 17.1 ... 18.6.7 Apr 02, 2009: LDR Corporation Receives US ... Device 18.6.8 Feb 26, 2009: Genzyme Announces FDA ... Top 10 Biotechnology Companies - SWOT Analysis, Competitive Benchmarking, Financial Analysis and R&D Pipeline   GBI Research, Feb 2010, Pages: 181 ... 9.7.1 Overview 10 Top 10 Biotechnology Companies ? Genzyme 10.1 Company Overview 10.1.1 ... Positioning 10.2.1 SWOT Analysis 10.3 Financial Analysis 10.3.1 ... Medtronic, Inc. Market Share Analysis   GlobalData, Nov 2009, Pages: 192 ... 15 Recent Developments 15.1 Strategy And Business ... To Reduce Global Workforce 15.2 Financial Announcements 15.2.1 ... La Roche Ltd Genzyme Corporation Integra Life ... Europe Orthopedic Devices Investment Opportunities, Analysis and Forecasts to 2012   Global Markets Direct, Feb 2009, Pages: 599 ... Corporation Company Profile 544 55 Genzyme Corporation Company Profile 548 56 ... Instrumental e Implantes Ltda Company Review 566 63 Financial Deals Landscape ... United States In Vitro Diagnostics Investment Opportunities Analysis and Forecasts to 2012   Global Markets Direct, Sep 2008, Pages: 164 ... Profile 140 31.1 Company Overview 140 32 Genzyme Corporation Company Profile 141 ... Company Profile 147 35.1 Company Overview 147 36 Financial Deals Landscape ... Orphan Drugs Pipeline Analysis: Wider Incentives Encourage Orphan Drug R&D   Decision Resources, Inc., July 2005, Pages: 107 ... company profiles and evaluate company financial information, Executive ... s disease resulted in Genzyme?s agalsidase ... and has provided financial incentives to ... United States Wound Care Management Investment Opportunities, Analysis and Forecasts to 2015   Global Markets Direct, Aug 2009, Pages: 172 ... Pipeline Products 17 Financial Deals Landscape 17.1 Acquisition ... 17.1.4 The Dow Chemical Company Acquires Rohm ... Files Class Action Suit Against Genzyme 18.2.2 ... Boston Scientific Medical Device Company Intelligence Report   Espicom Business Intelligence Ltd, Oct 2009, Pages: 84 ... as a full, in-depth five year financial analysis. ... 60 Medical Device Company Intelligence Reports ... Starion Instruments - VivoMetrics - Genzyme Biosurgery - Body1 ... Industry Analysis - How Companies Can Maintain the Market Success of Cancer MAbs   Decision Resources, Inc., Aug 2006, Pages: 30 ... Based to Product-Based Company Overflowing Clinical ... MAb Technologies 2 Financial Position of ... Genentech - Genmab - GenPharm - Genzyme - GlaxoSmithKline - Human ... US Wound Care Management Market Analysis and Forecasts to 2015   GlobalData, Sep 2009, Pages: 155 ... Financial Deal Analysis Deal Type 18.2 Financial Deal Analysis ... 18.3.4 The Dow Chemical Company Acquires Rohm and ... Files Class Action Suit Against Genzyme 19.2.2 ... Biotechnology Reagents - Global Strategic Business Report   Global Industry Analysts, Inc., Oct 2008, Pages: 759 ... II-38 The PLSG Makes Financial Investment in AIT II ... USA) - Geno Technology, Inc (USA) - Genzyme Diagnostics (USA) - Glen Research Corporation (USA) - Goodwin ... Results:  First -   Prev -   1 -   2 -   Next -   Last

		Top of page

All rights reserved. © Copyright 2010 Research and Markets1    Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster